Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : HT-ALZ
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : Hoth Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Details : This Sponsored Research Agreement with Washington University in St. Louis aims to support the continued research and development of HT-ALZ, a novel therapeutic for the treatment of symptoms related to Alzheimer's disease.
Product Name : HT-ALZ
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
July 06, 2021
Lead Product(s) : HT-ALZ
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : Hoth Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : VSV-SARS-CoV-2 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Experimental Covid-19 Vaccine Prevents Severe Disease in Mice
Details : The vaccine, which is made from a mild virus genetically modified to carry a key gene from the COVID-19 virus, is described in the journal Cell Host and Microbe.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
November 08, 2020
Lead Product(s) : VSV-SARS-CoV-2 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Bharat Biotech
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : This vaccine expands Bharat’s portfolio of vaccines that are currently being developed and are in various stages of clinical development including COVAXIN® which is currently in Phase II human clinical trials in India.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
September 23, 2020
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Bharat Biotech
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Lead Product(s) : ChAd-SARS-CoV-2-S
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : ChAd-SARS-CoV-2-S, a single-dose intranasal vaccine, prevents SARS-CoV-2 infection in both the upper and lower respiratory tracts of mice. ChAd-SARS-CoV-2-S vaccine incorporates two mutations into the spike protein that stabilize it in a specific shape f...
Product Name : ChAd-SARS-CoV-2-S
Product Type : Vaccine
Upfront Cash : Inapplicable
August 27, 2020
Lead Product(s) : ChAd-SARS-CoV-2-S
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chloroquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Rising Pharmaceuticals to Support Global Clinical Trial Conducted by the CROWN Collaborative
Details : An international study named “CROWN CORONATION” aims to include up to 55,000 subjects and is designed to assess the effectiveness of multiple dose ranges of chloroquine to prevent SARS-CoV-2 infection in frontline healthcare workers.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 18, 2020
Lead Product(s) : Chloroquine Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable